BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cooperative Research Centre for Diagnostics 

Q Block, QUT Gardens Point Campus
2 George Street
Brisbane  Queensland    Australia
Phone: 61-7-3864-4015 Fax:


SEARCH JOBS


The CRC for Diagnostics (CDx) brings together leading Australian-based diagnostic research organisations and end-users to provide a Centre for Excellence in the development of novel diagnostic technologies. The research portfolio can be divided into 5 broad streams:

  • Protein profiling - novel targets for diagnosis and monitoring of complex chronic diseases
  • High affinity reagents - novel reagents and new platforms for library construction and screening using compact protein domains and peptides
  • Genome diagnostics - human SNPs for physical characteristics, prostate cancer and genome stability
  • Infectious disease diagnostics - nucleic acid and antigen/antibody tests and microbial genotyping
  • Homogeneous reporter systems - analyte activation of enzymatic reporters

    Key research and innovation areas:
    CDx integrates protein and nucleic acid-based technologies, processes and products for rapid in vitro diagnosis and monitoring of human diseases and phenotypes. It develops platform technologies in molecular diversity, molecular interactions, genomics and proteomics for biomarker discoveries, target binding and reporter systems. CDx develops and exploits diagnostic platforms to enable more patient-specific screening for predisposition of selected diseases and medical conditions.

    Specific projects/technology offers:

  • Novel SNPs for human physical appearance
  • SNP genotyping technology for rapid bacterial identification and typing
  • Technology for production of generic positive control reagents for in vitro immunodiagnostic assays
  • Novel DNA amplification and detection methods
  • High affinity binding molecules, including novel compact protein domains and peptide libraries
  • Novel in vivo molecular evolution processes for improvement of binding reagents
  • Improvement of protein folding and expression in suitable recombinant protein expression systems

    Contact:

    Professor Ian Gardner
    CEO, CRC for Diagnostics
    Q Block, QUT Gardens Point Campus
    2 George Street
    Brisbane QLD AUSTRALIA
    Tel: 61-7-3864-4015

    Last Updated: 05-12-04

     Key Statistics


    Email:
    Ownership:

    Web Site: Cooperative Research Centre for Diagnostics
    Employees:
    Symbol: 
     



  • Industry
    Biotechnology






     Company News
    Currently No News Articles